Tower Research Capital LLC (TRC) - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,502
+35.5%
4,037
+15.7%
0.00%
Q2 2023$11,440
+81614.3%
3,488
-34.3%
0.00%
Q1 2023$14
-63.2%
5,310
-73.9%
0.00%
-100.0%
Q4 2022$38
-99.9%
20,316
-36.6%
0.00%
+100.0%
Q3 2022$59,000
+51.3%
32,065
+78.1%
0.00%0.0%
Q2 2022$39,000
+200.0%
18,003
+350.9%
0.00%
Q1 2022$13,000
+8.3%
3,993
+5.6%
0.00%
Q4 2021$12,000
-52.0%
3,781
-49.5%
0.00%
-100.0%
Q3 2021$25,000
+78.6%
7,491
+112.6%
0.00%
Q2 2021$14,000
-63.2%
3,524
-62.7%
0.00%
-100.0%
Q1 2021$38,000
-61.2%
9,438
-77.8%
0.00%
-66.7%
Q4 2020$98,000
-57.9%
42,557
+5.0%
0.00%0.0%
Q3 2020$233,000
+1356.2%
40,546
+1808.0%
0.00%
+200.0%
Q2 2020$16,000
-51.5%
2,125
-80.6%
0.00%
-50.0%
Q1 2020$33,000
-58.2%
10,967
-42.5%
0.00%
-71.4%
Q4 2019$79,000
+1216.7%
19,063
+484.0%
0.01%
Q2 2019$6,000
-64.7%
3,264
-65.8%
0.00%
-100.0%
Q1 2019$17,000
-26.1%
9,533
+2.6%
0.00%
-50.0%
Q4 2018$23,000
-36.1%
9,293
+45.8%
0.00%
-33.3%
Q3 2018$36,000
+620.0%
6,373
+780.2%
0.00%
Q1 2018$5,000
+150.0%
724
+194.3%
0.00%
Q3 2017$2,0002460.00%
Q2 2017$000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders